Medion Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 24-10-2024
- Paid Up Capital ₹ 1.33 M
as on 24-10-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.20 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.38 M
as on 24-10-2024
- Revenue 77.81%
(FY 2023)
- Profit 92.14%
(FY 2023)
- Ebitda 123.46%
(FY 2023)
- Net Worth 226.54%
(FY 2023)
- Total Assets 52.95%
(FY 2023)
About Medion Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.33 M.
The company currently has active open charges totaling ₹13.20 Cr. The company has closed loans amounting to ₹4.38 M, as per Ministry of Corporate Affairs (MCA) records.
Kapil Dev, Rinku Kumari, and Prateek Sachdeva serve as directors at the Company.
- CIN/LLPIN
U51909DL2012PTC234100
- Company No.
234100
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medion Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Dev  | Director | 09-Apr-2012 | Current |
| Rinku Kumari | Director | 04-Dec-2014 | Current |
| Prateek Sachdeva | Director | 11-Apr-2022 | Current |
Financial Performance of Medion Biotech.
Medion Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 77.81% increase. The company also saw a substantial improvement in profitability, with a 92.14% increase in profit. The company's net worth Soared by an impressive increase of 226.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medion Biotech?
Unlock access to Medion Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Feb 2024 | ₹6.20 Cr | Open |
State Bank Of India Creation Date: 30 Oct 2021 | ₹6.90 Cr | Open |
Hdfc Bank Limited Creation Date: 12 Nov 2020 | ₹1.00 M | Open |
How Many Employees Work at Medion Biotech?
Medion Biotech has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medion Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medion Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
